The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

Your Body Mass Index (BMI) is often an indicator to diagnose obesity. Combating obesity is paramount to overall health. According to The National Health Institute, 1 in 3 adults are considered ...

BMI misclassifies athletic bodies. New research calls for revised BMI cut-offs to better assess young male athletes’ health ...

A sleep specialist and an endocrinologist discuss ways to engage patients in difficult conversations and shared decision-making to better manage the related conditions of sleep apnea and obesity.

ANTIBIOTICS are one of the miracles of modern medicine. The drugs have transformed the treatment of deadly bacterial ...

Overall, Novo is expecting slower growth in 2025. The company is guiding for sales to rise between 16% and 24%, down from 26% ...

To Mantain your BMI partnering with health insurance providers like Star Health can provide comprehensive support for ...

The latest discovery in obesity medicine will be available in ... uneasy about needles benefit from these drugs and reduce weight, the media report said, citing dermatologist and anti-ageing ...

Eli Lilly gains ground with Orforglipron’s success, showing growth potential and risks from momentum and tariffs. Read why ...

How long it takes to lose weight can vary based on a number of factors, such as age, medications you take, your activity ...

Adults with obesity and prediabetes had a mean weight regain of 3.7% at 176 weeks after reaching their nadir weight loss. Response to tirzepatide may vary based on weight-loss trajectory.